Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biokinetics of F-18 FDG in Pediatric Imaging
NCT03107325Phase 4Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Feb 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fludeoxyglucose f 18 in Neoplasm, sponsored by Boston Children's Hospital. Planned start Feb 2019; status: withdrawn.
02
Drugs
fludeoxyglucose f 18
03
Conditions
Neoplasm
Beyond the preview
Go deeper on NCT03107325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107325.